Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study
Article first published online: 25 FEB 2005
DOI: 10.1111/j.1445-5994.2005.00790.x
Additional Information
How to Cite
Lin, M.-S., Dai, Y.-S., Pwu, R.-F., Chen, Y.-H. and Chang, N.-C. (2005), Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Internal Medicine Journal, 35: 188–190. doi: 10.1111/j.1445-5994.2005.00790.x
Publication History
- Issue published online: 25 FEB 2005
- Article first published online: 25 FEB 2005
- Received 15 June 2004;accepted 30 October 2004.
- Abstract
- Article
- References
- Cited By
Keywords:
- case-control study;
- Stevens-Johnson syndrome;
- toxic epidermal necrolysis;
- adverse drug reaction;
- relative risk
Abstract
The purpose of this case-control study is to estimate the risks of Stevens-Johnson syndrome or toxic epidermal necrolysis associated with the use of specific drugs. The suspected cases were identified from the computerized hospital discharge file. We calculated crude relative risks and adjusted them for confounding by multivariate analysis. The analysis was based on 35 cases and 105 controls. This study showed that the use of carbamazepine, phenytoin and allopurinol is most associated with the risks in the oriental population. (Intern Med J 2005; 35: 188–190)

1445-5994/asset/IMJ_left.gif?v=1&s=722ef184f9aa72bae1325726c13455ad3dbfce2e)
1445-5994/asset/IMJ_right.gif?v=1&s=6f6ad9c8c9af5b4790d0d9c33600f5165960a8dd)
1445-5994/asset/cover.gif?v=1&s=96495bf6d15ba48fc9883fd5742461b6cfff0418)